MTRR 66A > G polymorphism in relation to congenital heart defects

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 11, 2006, Pages 1317-1323

  Van Beynum, Ingrid M ^a   Kouwenberg, Margreet ^a   Kapusta, Livia ^a   Den Heijer, Martin ^a   Van Der Linden, Ivon J M ^a   Daniels, Otto ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Congenital heart defects; Methionine synthase reductase; Methylmalonic acid

Indexed keywords

CYANOCOBALAMIN; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLMALONIC ACID;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGENY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGE FACTORS; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; FERREDOXIN-NADP REDUCTASE; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; LINKAGE DISEQUILIBRIUM; MALE; METHYLMALONIC ACID; MIDDLE AGED; NETHERLANDS; NUCLEAR FAMILY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 33750742795     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.254     Document Type: Article

References (45)

1. Bakker MK, van den Berg MD, Boonstra A, van Diem MT, Meijer WM, ter Beek L, et al. EUROCAT Northern Netherlands Registration of congenital anomalies (Tables 1981-2002). Groningen: Department of Medical Genetics University Medical Centre, 2005:1-56.
2. Bruins CL, Temmermans AM. Kindercardiologie in Nederland in de tachtiger jaren [Pediatric cardiology in the Netherlands]. Verslag van NHS project 84-143: voorkomen en prognose van hart en vaatafwijkingen bij jeugdigen in Nederland [Report 84-143 of the Netherlands Heart Foundation]. The Hague: Netherlands Heart Foundation, 1990.
3. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
4. Tennstedt C, Chaoui R, Körner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 1999;82:34-9.
5. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
6. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
7. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-40.
8. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996;98:911-7.
9. Botto LD, Mulinare J, Erickson JD. Do multivitamin of folic acid supplements reduce the risk for congenital heart defects? Am J Med Genet 2003;121A:95-101.
10. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstst Gynecol Reprod Biol 1998;78:151-61.
11. Scalon KS, Ferencz C, Loffredo CA, Wilson PD, Correa-Villasenor A, Khoury MJ, et al. Periconceptional folate intake and malformations of the cardiac outflow tract. Epidemiology 1998;9:95-8.
12. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995;59:536-45.
13. van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniëls O, et al. Maternal MTHFR 677C > T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006;27:981-7.
14. Hobbs CA, James SJ, Parsian A, Krakowiak PA. Jernigan SL, Greenhaw JJ, et al. Congenital heart defects and genetic variants in the methylenetetrahydrofolate reductase gene. J Med Genet 2006;43:162-6.
15. Junker R, Kotthoff S, Vielhaber H, Halimeh S, Kosch A, Koch HG, et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001;51:251-4.
16. Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, et al. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 2005;138:21-6.
17. Storti S, Vittorini S, Iascone MR, Sacchelli M, Collavoli A, Ripoli A, et al. Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab Med 2003;41:276-80.
18. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001;184:806-17.
19. Hobbs C, Cleves MA, Melnyk S, Zhao W, James JS. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 2005;81:147-53.
20. Kapusta L, Haagmans ML, Steegers EA, Cuypers MH, Blom HJ, Eskes TK. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 1999;135:773-4.
21. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998;95:3059-64.
22. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002;41:13378-85.
23. Olteanu H, Banerjee R. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 2001;276:35558-63.
24. 12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-23.
25. Rasmussen K, Moelby L, Jensen MK. Studies on methylmalonic acid in humans. II. Relationship between concentrations in serum and urinary excretion, and the correlation between serum cobalamin and accumulation of methylmalonic acid. Clin Chem 1989;35:2277-80.
26. Pietrzyk JJ, Bik-Multanowski M, Sanak M, Twardowska M. Polymorphisms of the 5,10-methylenetetrahydrofolate and methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 2003;44:111-3.
27. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, et al. Homocysteine remethylation enzyme polymorphism and increased risk for neural tube defects. Mol Genet Metab 2003;78:216-21.
28. van der Linden IJ, den Heijer M, Afman LA, Gellekink HJ, Vermeulen SH, Kluijtmans LA, et al. The methionine synthase reductase 66A > G polymorphism is a maternal risk factor for spina bifida. J Mol Med 2006. In press.
29. van Beynum IM, den Heijer M, Thomas CM, Afman L, Oppenraay-van Emmerzaal D, Blom HJ. Total homocysteine and its predictors in Dutch children. Am J Clin Nutr 2005;81:1110-6.
30. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002;88:723-8.
31. Besson WT, Kirby ML, van Mierop LH, Teabeaut JR II. Effects of the size of lesions of the cardiac neural crest at various embryonic ages on incidence and type of cardiac defects. Circulation 1986;73:360-4.
32. Kirby ML, Turnage KL, Hays B. Characterization of conotruncal malformations following ablation of cardiac neural crest. Anat Rec 1985;213:87-93.
33. Yelbuz TM, Waldo KL, Kumiski DH, Stadt HA, Wolfe RR, Leatherbury L, et al. Shortened outflow tract leads to altered cardiac looping after neural crest ablation. Circulation 2002;106:504-10.
34. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
35. Barbaux S, Kluijtmans LA, Whitehead AS. Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism. Clin Chem 2000;46:907-12.
36. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001;157:451-6.
37. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995;57:455-64.
38. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
39. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, et al. The "Thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64:1045-55.
40. Jacques PF, Bostom AG, Selhub J, Rich S, Curtis ER, Eckfeldt JH, et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 2003;166:49-55.
41. Gellekink H, den Heijer M, Heil SG, Blom HJ. Genetic determinants of plasma total homocysteine. Semin Vasc Med 2005;5:98-109.
42. 12 concentrations in renal transplant patients. Atherosclerosis 2004;174:43-8.
43. Waldo K, Miyagawa-Tomita S, Kumiski D, Kirby ML. Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: aortic sac to ventricular septal closure. Dev Biol 1988;196:129-44.
44. Poelmann RE, Gittenberger-de Groot AC. A subpopulation of apoptosis-prone cardiac neural crest cells targets to the venous pole: multiple functions in heart development? Dev Biol 1999;207:271-86.
45. Gezondheidsraad/Voedingsraad. Vervolgadvies inzake foliumzuurvoorziening in relatie tot neurale buisdefecten. [Advice concerning folic acid intake in respect of neural tube defects.] The Hague: Voorlichtingsbureau voor de Voeding, 1993.